33
MINIMALLY INVASIVE AORTIC VALVE THERAPIES
Baylor Scott & White Heart and Vascular Hospital – Dallas continues to be one of the top volume centers in the US for commercial and research minimally invasive valve repair and replacement procedures . Since the early beginnings of TAVR , Robert Stoler , MD , medical director of the cardiac catheterization lab and co-director of the Division of Cardiology , and Paul Grayburn , MD , administrative director of the non-invasive lab in fiscal year 2020 , have conducted transcatheter mitral and aortic valve studies leading to FDA approval of new technologies for patients . Dr . Stoler , Dr . Grayburn and other implant physicians involved in the Center for Valve Disorders have proctored cases internationally on three TAVR devices , sharing knowledge from the multidisciplinary Dallas campus program .
Aortic valve research trials :
• Clinical trials available involving asymptomatic aortic stenosis , new generation valves and cerebral embolic protection
MINIMALLY INVASIVE MITRAL VALVE THERAPIES
For years , open heart surgery was the only treatment option for mitral regurgitation — when the heart ’ s mitral valve doesn ’ t close tightly , allowing blood to flow backward into the heart . Through the advancement of research and the clinical trials conducted by cardiologists on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas , mitral regurgitation can be treated using devices placed through a small incision in the groin .
Mitral valve research trials :
• Clinical trials available involving functional and symptomatic mitral regurgitation or mitral stenosis through transcatheter mitral valve repair and replacement using new generation technology
The Dallas campus is one of the highest volume sites using MitraClip ® and was involved in its initial trial , the COAPT Trial , which led to the evolution of this device .
Center for Valve Disorders medical staff team ( FY20 ):
Interventional cardiologists :
• James W . Choi , MD , FACC , FSCAI
• Paul Grayburn , MD , FACC
• Stuart Lander , MD , FACC
• Robert Stoler , MD , FACC , FSCAI
• Ravi Vallabhan , MD , FACC , FSCAI
Imaging cardiologists :
• Paul Grayburn , MD , FACC
• Haojie Wang , MD , PhD , FACC , RPVI
• Anumeha Tandon , MD ( July 2020 to present )
Cardiac surgeons :
• Daniel H . Enter , MD
• Robert F . Hebeler , Jr ., MD , FACS
• Albert Carl Henry , III , MD , FACS
• Aldo Rafael , MD
Advanced nurse practitioners :
• Mini Iype , MSN , MHA , RN-BC , FNP-C ( through March 2020 )
• Anna-Catherine Wolynec , FNP-BC ( April 2020 to present )
Baylor Scott & White Heart and Vascular Hospital – Dallas Center for Valve Disorders
Post-minimally invasive valve replacement patients discharged home with no additional care required :*
94 %
* STS / ACC TVT Registry Institutional Outcomes Report 2019Q4 R4Q